Prevalence of Epstein–Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|38|10|1248-1254

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.38, Iss.10, 2013-11, pp. : 1248-1254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population‐based cohort study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 2, 2015-02 ,pp. : 228-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12‐month multicentre observational prospective cohort study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 356-363

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epstein–Barr virus‐positive plasmacytoma in immunocompetent patients

By  

HISTOPATHOLOGY, Vol. 67, Iss. 2, 2015-08 ,pp. : 225-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammatory bowel disease in pregnancy: a population‐based study of prevalence and pregnancy outcomes

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 123, Iss. 11, 2016-10 ,pp. : 1862-1870

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epstein-Barr Virus Genotypes and Strains in Central Nervous System Demyelinating Disease and Epstein-Barr Virus-Related Illnesses in Australia

By  

Intervirology, Vol. 55, Iss. 5, 2012-01 ,pp. : 372-379

Karger

Access to resources Recommend Favorite